US Drug Recall Register
Class II · Moderate risk Terminated Initiated Sep 13, 2016 (10 years ago)

Desoximetasone Cream USP

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation).

What was recalled

Desoximetasone Cream USP, 0.05% 100 g, Rx only, mfd. by Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532; NDC 51672-1271-7

Recalling firm
Taro Pharmaceuticals, Inc.
NDC code
51672-1271-7
Origin
Canada
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0117-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Desoximetasone recalls

See all
Class II · Moderate risk Terminated

Desoximetasone Ointment USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-030-99 D-0678-2022
Class II · Moderate risk Terminated

Desoximetasone Ointment USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-045-99 D-0677-2022
Class II · Moderate risk Terminated

Desoximetasone Ointment USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 70512-037-10 D-0676-2022
Class II · Moderate risk Terminated

Desoximetasone Topical Spray

Reason Failed Impurities/Degradation Specification; high out of specification results observed

Lupin Pharmaceuticals Inc. D-0866-2020
Class II · Moderate risk Terminated

Desoximetasone USP

Reason CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

American Pharmaceutical Ingredients LLC NDC 58597-8634-2 D-0483-2018